EHNAC revises accreditation programs

 

The Electronic Healthcare Network Accreditation Commission (EHNAC), a standards development organization and accrediting body, has added new criteria to its accreditation programs.

The revised criteria apply to candidates beginning the accreditation or re-accreditation process in 2015. The organization has adopted the enhanced and final criteria versions for the following 15 accreditation programs:

  1. ACOAP - Accountable Care Organization Accreditation Program (V1.0)
  2. DTAAP-CA - Direct Trusted Agent Accreditation Program for Certificate Authorities (V1.2)
  3. DTAAP-HISP - Direct Trusted Agent Accreditation Program for Health Information Service Providers (V1.2)
  4. DTAAP-RA - Direct Trusted Agent Accreditation Program for Registration Authorities (V1.2)
  5. ePAP-EHN - e-Prescribing Accreditation Program (V6.7)
  6. EPCSCP-Pharmacy - Electronic Prescription of Controlled Substances Certification Program - Pharmacy Vendor (V1.3)
  7. EPCSCP-Prescribing - Electronic Prescription of Controlled Substances Certification Program - Prescribing Vendor (V1.3)
  8. FSAP-EHN - Financial Services Accreditation Program for Electronic Health Networks (V2.7)
  9. FSAP-Lockbox - Financial Services Accreditation Program for Lockbox Services (V2.7)
  10. HIEAP - Health Information Exchange Accreditation Program (V1.6)
  11. HNAP-EHN - Healthcare Network Accreditation Program for Electronic Health Networks [Includes Payer] (V10.7)
  12. HNAP-Medical Biller - Healthcare Network Accreditation Program for Medical Billers (V1.6)
  13. HNAP-TPA - Healthcare Network Accreditation Program for Third Party Administrators (V1.6)
  14. MSOAP - Management Service Organization Accreditation Program (V1.5)
  15. OSAP - Outsourced Services Accreditation Program1 (V1.7)

The updates enable covered entities to meet the most current federal and state healthcare reform mandates. The latest versions include new criteria regarding the use of cloud service providers, and modifications were made to the OSAP program for outsourced HIE technology providers, as well as significant changes to the DTAAP-HISP program to further qualify HISPs, according to EHNAC.

Review the revised criteria.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.